Chris Garabe­di­an's Xon­toge­ny shep­herds its first biotech through a $10M start­up round

Four months af­ter Chris Garabe­di­an lined up $15 mil­lion to back his new play to shep­herd a flock of biotech star­tups, the Xon­toge­ny CEO …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.